Minimally invasive endoscopic surgery for brain bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a sudden bleeding in the brain (supratentorial intracerebral hemorrhage) shown on imaging
- The bleed size is at least 20 mL but less than 100 mL
- You have new, significant symptoms such as weakness on one side, language trouble, neglect of one side, or decreased alertness
- The team can start the endoscopic evacuation within 24 hours of last being well or symptoms starting
- Your blood-clotting status can be corrected in time (INR must be 1.5 or less, if not correctable by the procedure time, you may not qualify)
- You did not have major disability before this bleed (mRS must be 2 or less)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This trial tests whether a minimally invasive brain surgery using an endoscope can improve outcomes for people with a deep brain bleed. It also studies the safety of this approach compared with standard care.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
Hear when a new Intracerebral Haemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.